capitation;
health care expenditures;
national health insurance;
CARE EXPENDITURES;
INSURANCE CLAIMS;
MEDICARE;
D O I:
10.1177/1355819615577711
中图分类号:
R19 [保健组织与事业(卫生事业管理)];
学科分类号:
摘要:
Objectives The National Health Insurance (NHI) system in Taiwan launched a trial capitation provider payment programme in 2011, with the capitation formula based on patients' average NHI expenditure in the previous year. This study seeks to examine the concentration and persistence of health care expenditure among the elderly, and to assess the performance of the current capitation formula in predicting future high-cost users. Methods This study analysed NHI expenditures for a nationally representative sample of people aged 65 years and over who took part in Taiwan's National Health Interview Survey, 2005. Expenditure concentration was assessed by the proportion of NHI expenditures attributable to four groups by expenditure percentile. Four transition probability matrixes examined changes in a person's position in the expenditure percentiles and generalized estimation equation models were estimated to identify significant predictors of a patient being in the top 10% of users. Results Between 2005 and 2009, the top 10% of users on average accounted for 55% of total NHI expenditures. Of the top 10% in 2005, 39% retained this position in 2006. However, expenditure persistence was the highest (77%) among the bottom 50% of users. NHI expenditure percentiles in both the baseline year and the prior year, and chronic conditions all significantly predicted future high expenditures. The model including chronic conditions performed better in predicting the top 10% of users (c-statistics increased from 0.772 to 0.904) than the model without. Conclusions Given the increase in predictive ability, adding chronic conditions and baseline health care use data to Taiwan's capitation payment formula would correctly identify more high users.
机构:
Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
Lin, Pei-Jung
;
Biddle, Andrea K.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Global Publ Hlth, Chapel Hill, NC USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
Biddle, Andrea K.
;
Ganguly, Rahul
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Global Hlth Outcomes, Res Triangle Pk, NC USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
Ganguly, Rahul
;
Kaufer, Daniel I.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
Kaufer, Daniel I.
;
Maciejewski, Matthew L.
论文数: 0引用数: 0
h-index: 0
机构:
Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA
Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
机构:
Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
Lin, Pei-Jung
;
Biddle, Andrea K.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Global Publ Hlth, Chapel Hill, NC USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
Biddle, Andrea K.
;
Ganguly, Rahul
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline Inc, Global Hlth Outcomes, Res Triangle Pk, NC USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
Ganguly, Rahul
;
Kaufer, Daniel I.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
Kaufer, Daniel I.
;
Maciejewski, Matthew L.
论文数: 0引用数: 0
h-index: 0
机构:
Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA
Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USATufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA